Evidence map›Paper›PMID 28924518›Full record

ArticleCureus2017

Clinical Spectrum of Chikungunya in Pakistan.

Syeda Naqvi, Shehroz Bashir, Chintan Rupareliya, Abdullah Shams, Pirthvi Raj Giyanwani, Zeeshan Ali, Faiza Qamar, Vijesh Kumar, Vikash Talib

Open access · diamondAbstract read
In one paragraph

Article in Cureus, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Syeda NaqviJinnah Postgraduate Medical Centre, Jinnah Sindh Medical University (SMC).
Shehroz BashirMedicine Unit 7, Jinnah Sindh Medical University (SMC).
Chintan RupareliyaDepartment of Neurology, University of Missouri, Columbia, Missouri.
Abdullah ShamsInternal Medicine, CMH Lahore Medical and Dental College.
Pirthvi Raj GiyanwaniCivil Hospital Karachi, Dow University of Health Sciences (DUHS), Karachi, Pakistan.
Zeeshan AliJinnah Postgraduate Medical Centre, Jinnah Sindh Medical University (SMC).
Faiza QamarJinnah Postgraduate Medical Centre, Jinnah Sindh Medical University (SMC).
Vijesh KumarJinnah Postgraduate Medical Centre, Jinnah Sindh Medical University (SMC).
Vikash TalibAccident & Emergency, Jinnah Sindh Medical University (SMC).
Jinnah Postgraduate Medical Center · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Chikungunya fever is a pandemic disease caused by an arthropod-borne chikungunya virus (CHIKV). The virus spreads through mosquitoes. This mosquito induced viral illness is clinically suspected on symptoms from fever and severe polyarthralgia. The recent outbreak of chikungunya was reported in November 2016 in the metropolitan city Karachi, Pakistan. We emphasis on the awareness of the etiology and vector control to prevent serious consequences. Method A total number of 1275 patients were included in this cross-sectional study. These patients were enrolled based on clinical findings described by Centers for Disease Control and Prevention (CDC). Our exclusion criteria were patients with missing data or having co-infection with dengue or malaria. The patients were tested for chikungunya antibodies, malaria, and dengue. The patients were followed for three months. Results Out of 1275 consenting patients from the emergency department, 564 tested positive for chikungunya antibodies and out of these 564 patients 365 had co-infection of dengue and malaria. So based on exclusion criteria, 199 patients had isolated chikungunya infection and were studied for the frequency of clinical symptoms. The most common finding was joint pain and fever on presentation and joint pain was the only chronic finding which persisted. Conclusion Our study demonstrated the frequency of clinical findings in chikungunya infection. It also signifies the importance of testing for antibodies because it helped in excluding patients with false positive clinical findings and differentiating co-infection with malaria and dengue. It also gauged patient's view about the cause of this disease.

Indexed as

analgesicsarthralgiachikungunyafeverheadachemosquitopublic awarenesspurpuraviral fevervirus

Identifiers

PMID28924518
PMCPMC5587410
OpenAlexW2730504105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.